Brembilla-Perrot B, Terrier de la Chaise A, Skeik L, Cherrier F, Pernot C
CHU Brabois, Vandoeuvre-lès-Nancy.
Arch Mal Coeur Vaiss. 1987 Sep;80(10):1497-503.
The purpose of this study was to search for factors correlated with the absence of reinduction of a clinical ventricular tachycardia (VT) by stimulation in patients under anti-arrhythmic treatment. Repeated stimulations were performed in 41 patients with spontaneous VT and sustained, monomorphous ventricular arrhythmia induced by stimulation. The stimulation included 1 or 2 extrastimuli delivered into the right ventricle in sinus rhythm, then in imposed ventricular rhythm (600-400 ms). At least 4 anti-arrhythmic drugs were tested. In 16 patients (group I) of mean age 51 +/- 11 years VT was no longer reinducible under anti-arrhythmic treatment. In 25 patients (group II) of mean age 57 +/- 12 years no anti-arrhythmic drug was able to prevent VT induction. The characteristics of spontaneous and induced VT and of isotopic left ventricular ejection fraction (LVEF) were compared in both groups. The absence of reinduction of VT was obtained more easily in patients with: spontaneous, frequently unsustained VT; VT requiring 2 ventricular extrastimuli delivered in imposed rhythm to be induced; rapid initial induced VT (cycle 233 +/- ms vs 297 +/- 63 ms); less advanced underlying heart disease (LVEF 38 +/- 18 vs 27 +/- 13%). The subsequent history of the patients showed that the absence of reinduction of VT was correlated with a low risk of recurrence of VT (12.5 vs 48%) and with a lower risk of mortality (6% vs 32%) than in patients whose VT was always inducible under anti-arrhythmic treatment.
本研究的目的是寻找在抗心律失常治疗的患者中,与刺激未能再次诱发临床室性心动过速(VT)相关的因素。对41例有自发性VT且能被刺激诱发持续性、单形性室性心律失常的患者进行了重复刺激。刺激包括在窦性心律下,然后在强制心室节律(600 - 400毫秒)时向右心室发放1或2个期外刺激。至少测试了4种抗心律失常药物。在16例平均年龄为51±11岁的患者(I组)中,抗心律失常治疗下VT不再能被诱发。在25例平均年龄为57±12岁的患者(II组)中,没有抗心律失常药物能够预防VT的诱发。比较了两组患者自发性和诱发性VT以及同位素左心室射血分数(LVEF)的特征。在以下患者中更容易出现VT不能再次诱发的情况:有自发性、频繁非持续性VT;VT需要在强制节律下发放2个心室期外刺激才能诱发;初始诱发的VT较快(周期233±毫秒对297±63毫秒);基础心脏病不太严重(LVEF 38±18对27±13%)。患者的后续病史显示,与抗心律失常治疗下VT始终能被诱发的患者相比,VT不能再次诱发与VT复发风险较低(12.5%对48%)以及死亡风险较低(6%对32%)相关。